Instalab
logoInstalab

Total Fat Mass

See how much of your body is actually fat, not just what you weigh, often before it shows up in your blood sugar.
4.9 (4,003 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Total Fat Mass test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
You feel fine and want an honest read on how much fat you carry and whether it is creeping up before any blood test flags it.
Normal Weight but Not Sure You're Lean
The scale and BMI look fine, but you want to know whether hidden fat is quietly raising your risk of diabetes.
Losing Weight on a GLP-1 or Diet
You want to confirm the weight coming off is actually fat, not the muscle you need to protect.
Diabetes or Heart Disease in the Family
A family history of diabetes or heart trouble means knowing your fat load early gives you years to act on it.

About Total Fat Mass

Two people can weigh exactly the same and carry wildly different amounts of fat. One is mostly muscle, the other mostly not. Total fat mass is the number that tells them apart, and the bathroom scale never will.

It also tends to move early. In a study that followed thousands of teenagers, higher fat mass showed up first and insulin resistance followed, not the other way around. That ordering is the whole reason to watch this number: it can shift before your standard labs do.

What the Number Actually Is

Total fat mass is the weight of all your fat tissue added together. Fat is stored inside fat cells as triglycerides, a compact way to bank energy your body can draw on later. This is different from body fat percentage, which is that same fat weight expressed as a share of your total body weight.

Fat tissue is not inert padding. It behaves like a gland, releasing signaling molecules such as leptin and adiponectin that talk to your liver, muscles, and brain. When there is too much fat, or fat sitting in the wrong places, that signaling turns inflammatory and pushes you toward insulin resistance. The number itself is usually measured by a body scan (DXA is the reference method) or by sending a small electrical current through the body (impedance).

Fat, Blood Sugar, and Diabetes

This is where fat mass earns its keep. In a nine-year study of about 3,000 adolescents, each extra kilogram of fat carried through the teenage years raised the odds of insulin resistance worsening by about 12 percent. Fat around the trunk mattered more, raising those odds by about 21 percent.

The sequence pointed one way. More fat at age 15 came before insulin resistance at age 17, and the reverse path was not there. If you are trying to catch metabolic trouble before it becomes diabetes, watching fat mass gives you a genuine head start.

Heart Disease

Where fat sits changes everything. In postmenopausal women whose BMI looked perfectly normal, more fat around the trunk carried nearly twice the heart disease risk, while more fat on the legs was linked to roughly 38 percent lower risk. Two women with identical total fat can face very different odds depending on the map.

When researchers combine fat with muscle into a single fat-to-muscle ratio, the signal sharpens further. A higher ratio was tied to about 63 percent more cardiovascular disease in men and 83 percent more in women, and it beat BMI at predicting cardiovascular death in that analysis, though not every study agrees that body-composition measures outperform BMI. That combined ratio is a related measure, not total fat mass alone, but it makes the point: fat matters most when read against the muscle you carry.

The Mortality Curve Bends at Both Ends

Pooled across seven cohorts, fat mass and death traced a J-shape: risk was lowest in a middle range and climbed at both extremes. People at the high end (fat scaled to height at 13 versus about 7) had roughly 56 percent higher risk of dying during the studies. A separate dose-response analysis put the low point near 20 kilograms of fat, or about 25 percent body fat.

The mirror image is more complicated than it first looks. In the same studies, fat-free mass (your muscle, bone, and organs) was protective, and very low fat often travels with too little muscle. But the uptick in risk at the low-fat end likely reflects underlying illness, smoking, and reverse causation rather than the low fat itself; genetic studies point to a more linear link, where higher fat mass, not lower, is what raises mortality.

Cancer

Among about 1,700 cancer survivors, those carrying more total fat had roughly 30 percent higher risk of dying from any cause, though not specifically from their cancer. The effect appeared larger in men than in women, though the exact sex-specific figures are less certain.

What this means for you: fat mass here is less a cancer-detection tool than a marker of overall resilience. If you are a survivor, tracking fat and muscle together is a practical way to gauge whether your body is holding its ground.

Why More Fat Isn't Always the Problem, and Less Isn't Always the Fix

Some findings look backwards until you see the pattern. People with lipodystrophy, who are missing much of their fat tissue, develop severe insulin resistance and diabetes. Surgically removing subcutaneous fat by liposuction has produced inconsistent effects on insulin resistance, with some studies showing little metabolic benefit and others finding modest drops in fasting insulin. And a class of diabetes drugs actually adds fat while improving insulin sensitivity. Even higher fat-free mass, usually assumed protective, has been tied to greater odds of metabolic syndrome in one large survey.

Here is the framework that makes all of this consistent. Total fat mass is not a good-number, bad-number marker. It is a snapshot of one part of a system, and what determines your risk is where that fat sits and whether it is working. Healthy fat tissue safely stores excess calories in the right places. Overloaded or misplaced fat spills lipids into your liver, heart, and muscle, and that is what drives disease. So the same amount of fat can be protective in one person and dangerous in another.

How It Shifts With Age

Fat does not just accumulate with age, it migrates. Over time the body tends to move fat away from the lower body and pack more into the abdomen and around the organs, sometimes even when total fat and weight barely change. That inward shift is the metabolically risky one.

Menopause gets blamed for the rise in fat, but a large analysis found the increase in total fat was driven mostly by aging itself rather than menopause. The redistribution toward the middle, however, does appear tied to the hormonal shift. The lesson is to watch the trend and the location, not just the total.

Why One Reading Isn't Enough

A single fat mass number is noisier than it looks. Under standardized conditions, modern scans and multifrequency impedance devices are fairly reliable, but impedance readings still shift with hydration, so a measurement taken while over- or under-hydrated can land you in a different spot than a repeat the next morning would.

The fix is trajectory. Get a baseline, repeat in three to six months if you are actively changing your diet or training, then at least once a year. A number moving in the wrong direction over several checks means far more than any single scan, and it is the only way to know whether what you are doing is actually working. Use the same method and device each time, because the numbers do not transfer cleanly between machines, and even two DXA scanners from different manufacturers can disagree.

What to Do With an Out-of-Pattern Result

A fat mass number is most useful read alongside a few companions. Pair it with a measure of fat distribution (waist or visceral fat) and with metabolic labs: fasting insulin or HOMA-IR, triglycerides, and hs-CRP (a marker of body-wide inflammation). Fat mass tells you how much; these tell you whether it is causing harm.

Watch for combinations, not single values. Normal weight with high trunk fat, rising fasting insulin, and high triglycerides is a metabolic pattern worth acting on even if the scale looks fine. If your fat mass is unusually low alongside signs of insulin resistance, that unusual pairing is worth an endocrinologist's eye rather than reassurance. A scan cannot see fat hidden inside your liver or pancreas, so pairing it with liver markers closes part of that gap.

When the Number Can Fool You

A few things can make a single reading misrepresent you:

  • Hydration and timing: impedance scales read differently depending on fluid balance. For a reliable number, measure at the same time of day, after an overnight fast, and away from heavy exercise, alcohol, and caffeine.
  • Method mismatch: impedance often reads fat mass differently from a DXA scan, sometimes by several kilograms, and the size and direction of that gap depend on the device and your body size. Comparing an impedance number to an old DXA number can invent a change that is not real.
  • A normal BMI: BMI cannot tell fat from muscle, and some people with a normal BMI carry enough hidden fat in the liver to develop diabetes. A reassuring weight does not rule out a problematic fat load.
  • Recent illness or big weight swings: acute illness and rapid loss shift the balance of fat and muscle in ways a one-time reading can misjudge.

None of these change the biology of your fat. They change what a single measurement shows, which is exactly why the trend beats the snapshot.

What Moves This Biomarker

Evidence-backed interventions that affect your Total Fat Mass level

Decrease
GLP-1 receptor agonists (such as semaglutide and tirzepatide)
These drugs shrink your fat stores, not just the number on the scale. Pooled across randomized trials, they lowered fat mass by about 3 kg on average, and with the most potent agents fat came off about three times faster than lean tissue. The catch worth planning around: roughly a quarter to a third of the total weight lost is muscle depending on the study, so pairing them with resistance training protects the muscle you want to keep.
MedicationStrong Evidence
Decrease
Sustained calorie restriction
Eating fewer calories than you burn is the core driver of fat loss, and lower-calorie diets produce larger short-term reductions in fat mass. The trade-off is durability: without ongoing effort and strength training, the fat tends to return and some of what is lost is muscle.
DietStrong Evidence
Decrease
Resistance (strength) training
Lifting weights lowers fat mass and body fat percentage while building the muscle that improves your fat-to-muscle balance, so it moves both sides of the metabolic equation. Meta-analyses in adults with overweight or obesity found the fat-loss effect is strongest when strength training is combined with eating fewer calories.
ExerciseModerate Evidence
Decrease
Aerobic and high-intensity interval training
Sustained cardio and interval work reduce total fat, and they are particularly effective at cutting abdominal and visceral fat, the deposits most tied to heart and metabolic risk. A meta-analysis of interval training found reductions across total, abdominal, and visceral fat.
ExerciseModerate Evidence
Decrease
Very-low-calorie ketogenic diet
A very-low-calorie ketogenic diet drives weight loss that comes mainly from fat mass and visceral fat while largely sparing muscle mass and strength. This makes it a fat-targeted approach, though the evidence here is from a small, non-randomized study.
DietModerate Evidence

Frequently Asked Questions

References

38 studies
  1. A. Agbaje, Christoph Saner, Jie Zhang, M. Henderson, T. TuomainenThe Journal of Clinical Endocrinology and Metabolism2024
  2. A. Sedlmeier, S. Baumeister, a. Weber, B. Fischer, B. Thorand, T. Ittermann, M. Dörr, S. Felix, H. Völzke, a. Peters, M. LeitzmannThe American Journal of Clinical Nutrition2021
  3. Ahmad Jayedi, T. Khan, D. Aune, Alireza Emadi, Sakineh Shab-bidarInternational Journal of Obesity2022
  4. L. Aduse-poku, S. Karanth, M. Wheeler, Danting Yang, C. Washington, Young-rock Hong, T. Manini, J. Fabregas, T. Cheng, D. BraithwaiteCancers2023